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AbstrAct
Objective Financial incentives associated with private 
insurance may encourage healthcare providers to 
perform more caesarean sections. We therefore sought to 
determine the association of private insurance and odds of 
caesarean section.
Design Systematic review and meta-analysis.
Data sources MEDLINE, Embase and The Cochrane 
Library from the first year of records through August 2016.
Eligibility criteria We included studies that reported 
data to allow the calculation of OR of caesarean section 
of privately insured as compared with publicly insured 
women.
Outcomes The prespecified primary outcome was the 
adjusted OR of births delivered by caesarean section of 
women covered with private insurance as compared with 
women covered with public insurance. The prespecified 
secondary outcome was the crude OR of births delivered 
by caesarean section of women covered with private 
insurance as compared with women covered with public 
insurance.
results Eighteen articles describing 21 separate studies 
in 12.9 million women were included in this study. In a 
meta-analysis of 13 studies, the adjusted odds of delivery 
by caesarean section was 1.13 higher among privately 
insured women as compared with women with public 
insurance coverage (95% CI 1.07 to 1.18) with no relevant 
heterogeneity between studies (τ2=0.006). The meta-
analysis of crude estimates from 12 studies revealed 
a somewhat more pronounced association (pooled OR 
1.35, 95% CI 1.27 to 1.44) with no relevant heterogeneity 
between studies (τ2=0.011).
conclusions Caesarean sections are more likely to 
be performed in privately insured women as compared 
with women using public health insurance coverage. 
Although this effect is small on average and variable in its 
magnitude, it is present in all analyses we performed.
IntrODuctIOn
The global raise of caesarean section (CS) 
rates during the past decades has raised 
concerns over appropriateness of usage of 
the procedure.1 2 The increase and immense 
variation among countries’ regions and hospi-
tals has been persistent over the years.3–14 
Brazil has the highest rate of CS followed by 
China, Turkey and Mexico.15 USA and other 
developed countries are not far behind. 
Even countries that traditionally have had 
low CS rates, like Norway or Sweden, have 
seen substantial increase in CS rates.15 This 
increase has been accompanied with consid-
erable variation within countries.15 In the 
USA, there was a fourfold difference in CS 
rates in low and high use areas.15 In England, 
the rates have varied threefold among 
National Health Service trusts.15 In British 
Columbia, Canada, the CS rates varied from 
14.7% to 27.6% across health service delivery 
areas.15 The understanding of escalation of 
CS rates is important as it may prevent nega-
tive outcomes on health of mothers and 
newborns as well as reduce unnecessary costs 
related to delivery.
Such increase and variation cannot 
be explained by clinical factors alone.15 
Evidence points to many additional, health 
system related factors, in particular suppli-
er-related factors.15 Financial incentives such 
as higher payment for CS and specifics 
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Research
strengths and limitations of this study
 ► Our meta-analysis includes a broad literature 
search, screening and data extraction performed 
in duplicate, an exploration of study characteristics 
as a potential source of variation between studies 
and firm quality assessment and represents major 
strength of our study.
 ► Sensitivity analyses was performed involving 
studies that required exclusion in main analysis due 
to overlapping populations.
 ► The differences in the characteristics of the study 
populations, type of data used, types of CS analysed 
and variables used for adjustment in statistical 
analyses across studies represent a major limitation 
of our study.
 ► Unadjusted estimates of associations were larger, 
which suggests the presence of confounding, and 
we cannot completely rule out residual confounding 
in adjusted estimates.
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of reimbursement arrangements linked with private 
insurance seem to influence supplier behaviour, be that 
physician or hospital, affecting this way clinical deci-
sion as to whether perform CS or not.14–22 We therefore 
performed a systematic review and meta-analysis to deter-
mine the association of insurance status of women with 
the odds of delivery by CS.
MAtErIAls AnD MEthODs
Search strategy and data sources
We combined search terms indicating CS, such as 
‘caesarean section’, ‘caesarean delivery’ and ‘caesarean’, 
with search terms associated with the study design such 
as ‘small area analysis’, ‘medical practice variation’ and 
search terms associated with determinants of variation 
and increase of CS rates. We did not restrict search by type 
of language or publication date. We searched MEDLINE, 
Embase and The Cochrane Library from inception to 
4 August 2016, when the search was last updated. In 
addition, we manually searched the reference lists of all 
included studies and earlier systematic reviews that we 
identified.
study selection and outcomes
To be eligible for inclusion, studies had to report data 
to allow the calculation of OR of CS comparing women 
covered by private insurance with women covered by 
public insurance in a specific healthcare system. The 
prespecified primary outcome was the adjusted OR of 
births delivered by CS of women covered with private 
insurance as compared with women with public insur-
ance coverage. The prespecified secondary outcome was 
the crude OR of CS of women covered with private insur-
ance as compared with women with public insurance.
Data extraction
Two researchers (IH and MB) screened the papers and 
extracted data independently. Data from full-text articles 
were extracted onto a data extraction sheet designed 
to capture data on study population, study design, data 
sources, setting, type of CS analysed and statistical anal-
ysis. We extracted adjusted and/or unadjusted ORs of 
CS of women with private insurance as compared with 
CS of women with public insurance. Differences among 
researchers with regards to study inclusion and data 
extraction procedure were resolved by consensus and 
consultation with other authors.
Quality assessment
Quality assessment was performed using the Quality In 
Prognostic Studies (QUIPS) tool.23 The QUIPS is used 
to assess risk of bias in prognostic studies across six 
domains including: selection bias, attrition bias, measure-
ment bias of prognostic factor, measurement bias of 
outcome, confounding and bias related to the statis-
tical analysis and presentation of results.23 We decided 
to use QUIPS tool as it seemed the most appropriate to 
perform quality assessment of the studies under investi-
gation. Only minor adjustment of the original tool was 
performed; that is, we added the option ‘not applicable’ 
in rating of items assessed for judging domains of bias. 
Each study was read in full and evaluated independently 
by two researchers (IH and MB). We used three levels of 
rating, that is, ‘high’, ‘moderate’ or ‘low’ to assess the risk 
of bias for all domains.23 Any assessment differences were 
discussed, and a single rating was assigned to each study. 
A study was judged with a high or a moderate risk of bias 
in case only one of the domains was assessed with a high 
or a moderate risk of bias. A study was judged with a low 
risk of bias in case all the six domains were rated with a 
low risk of bias.
Main analysis
We used standard inverse-variance random effects 
meta-analysis to estimate the pooled OR. An OR above 
1 indicates that CS are more frequently performed in 
women with private insurance than in women with public 
insurance. We calculated the variance estimate τ2 as a 
measure of heterogeneity between studies.24 We prespec-
ified a τ2 of 0.04 to represent low heterogeneity, 0.16 to 
represent moderate and 0.36 to represent high heteroge-
neity between studies.25 We conducted analyses stratified 
by study design, period of data collection, country, type 
of CS analysed, parity, inclusion of women with previous 
CS, pregnancy risk of included women and QUIPS risk 
of bias to investigate potential reasons for between-study 
heterogeneity and used χ2 tests to calculate p values for 
interaction, or tests for linear trends in cases of more than 
two ordered strata. All p values are two sided.
sensitivity analyses
Five studies26–30 were excluded from the main analysis, as 
they had an overlapping population with a larger study31 
that was included. For this reason, we repeated all anal-
yses including these five studies26–30 while excluding the 
larger one.31 Finally, we visually inspected a funnel plot of 
adjusted ORs against their SEs to address potential small 
study effects.32 We used STATA, V.13, for all analyses.
Patient involvement
No patients were involved in this study. We used data from 
published papers only.
rEsults
We identified a total of 1490 records with our search 
strategy (figure 1): 935 from MEDLINE; 494 from 
Embase; 38 from the Cochrane Library; and 23 from 
manual search. After removing duplicates, we screened 
1264 records for eligibility, and we retained 166 for full-
text examination. We excluded another 124 that did not 
report insurance status of women, 23 that were otherwise 
irrelevant and 1 study that had an overlapping popula-
tion. Finally, 18 articles describing 21 separate studies 
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Figure 1 The flow diagram of review.
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in 12.9 million women were included in review and 
meta-analysis.
Characteristics of studies are presented in table 1 
and online supplementary appendices 1–3. Sixteen 
studies were cross-sectional; five were retrospective 
cohort studies. Only one study used surveys, 18 hospital 
records, seven birth registries and one census data. All 
studies were published in English. Most studies were from 
the USA. Nineteen studies included the entire popula-
tion of eligible cases, while only two studies selected cases 
randomly. Case exclusion criteria varied considerably: 
one study excluded women aged 14 years and younger; 
three excluded multiparas; eight excluded women with 
previous CS; eight excluded stillbirths and nine multiple 
births; six excluded cases with specific presentations of 
the fetus; six studies excluded preterm births; and 13 
studies excluded cases due to provider characteristics. 
Two studies reported ORs of CS for which indication was 
established before labour (including CS on maternal 
request) only, 3 studies reported CS for which indication 
was established during labour and 16 studies reported 
ORs of any CS irrespective of indication. Seventeen 
studies adjusted for different characteristics as presented 
in online supplementary appendix 3. Quality assessment 
is presented in supplementary appendices 4 and 5. No 
studies were excluded due to quality assessment result. 
Five studies were rated with high risk of bias, 10 studies 
with moderate risk of bias and 6 studies with low risk of 
bias.
Figure 2 presents the meta-analysis of the 13 studies 
that reported adjusted ORs31 33–42; all of them using 
public insurance as the reference group. Overall, the 
odds of receiving CS were 1.13 higher for women with 
private insurance coverage as compared women with 
public health insurance coverage (95% CI 1.07 to 
1.18), with no relevant heterogeneity between studies 
(τ2=0.006). Figure 3 presents results of stratified anal-
yses of adjusted ORs. Estimates varied between strata, in 
particular for country (p for interaction <0.001), type of 
CS (p for interaction=0.001), inclusion of women with 
previous CS (p for interaction=0.006) and pregnancy 
risk (p for interaction <0.001). Online supplementary 
appendix 6 shows a funnel plot of adjusted ORs against 
their SEs on a log scale; there was no evidence for small 
study effects. Figure 4 presents the meta-analysis of crude 
ORs with a slightly stronger average association (pooled 
OR 1.35, 95% CI 1.27 to 1.44) and no relevant heteroge-
neity between studies (τ2=0.011).  Online supplementary 
appendix 7 presents adjusted associations for different 
states in the USA. Adjusted estimates ranged from 0.96 in 
Maryland to 1.54 in New Jersey.
Online supplementary appendices 8–10 report 
results from sensitivity analyses after inclusion of five 
smaller studies26–30 and exclusion of a larger study31 
that had overlapping populations with the five smaller 
ones. Online supplementary appendix 8 shows the 
meta-analysis of the 16 studies26–29 33–42 with a pooled 
adjusted OR of 1.14 (95% CI 1.07 to 1.22) and no 
evidence for relevant heterogeneity between studies 
(τ2=0.015).  Online supplementary appendix 9 pres-
ents results of stratified analyses, with estimates varying 
between countries (p for interaction <0.001), type of CS 
(p for interaction=0.007) and pregnancy risks (p for inter-
action <0.001). Finally, online supplementary appendix 
10 presents the meta-analysis of crude ORs, again with a 
stronger association on average (pooled OR 1.33, 95% CI 
1.25 to 1.41) and no relevant heterogeneity between 
studies (τ2=0.014).
DIscussIOn
Our systematic review and meta-analysis estimated that 
the overall odds of receiving a CS are on average 1.13 
times higher for privately insured women compared with 
women covered with public insurance. The increased risk 
was observed across all subgroups of studies in stratified 
analyses as well as in sensitivity analysis.
context
To our knowledge, this is the first meta-analysis to 
examine the association of CS rates with types of insur-
ance. A recently published meta-analysis found that the 
odds of delivery by CS was 1.41 higher in for-profit hospi-
tals as compared with non-profit hospitals (95% CI 1.24 to 
1.60).22 These findings were confirmed across subgroups 
(ie, such as country, year or study design) of studies in 
stratified analyses, indicating financial incentives may 
play an important role in such outcome.22 We found three 
other recent meta-analyses that summarised CS studies 
and found a strong association with obesity,43 sub-Sa-
haran Africa ethnic origin44 and labour induction.45 Our 
estimates of a 13% increase are on the lower end of the 
strength of associations found in earlier studies.
strengths and limitations
The major strengths of our meta-analysis include a broad 
literature search (online supplementary appendix 10), 
screening and data extraction performed in duplicate, an 
exploration of study characteristics as a potential source 
of variation between studies, sensitivity analyses involving 
studies that required exclusion due to overlapping popu-
lations and firm quality assessment using QUIPS tool. 
Major limitations are differences in the characteristics 
of the study populations, type of data used, types of CS 
analysed and variables used for adjustment in statistical 
analyses across studies. Unadjusted estimates of asso-
ciations were larger, which suggests the presence of 
confounding, and we cannot completely rule out residual 
confounding in adjusted estimates.
Mechanisms
Existing evidence suggests that possible causes for higher 
odds of CS in women insured privately lie in the differences 
in payment for CS and reimbursement arrangements 
among insurers as well as providers’ responses to these 
arrangements. In the countries included in our analysis, 
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Figure 2 Adjusted OR of caesarean section.
Figure 3 Stratified analyses/legend: *p for trend. QUIPS, Quality In Prognostic Studies.
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Figure 4 Crude OR of caesarean section.
private health insurers generally reimburse hospitals at 
higher fees for providing a CS compared with the public 
insurers.36 This incentive is heightened when public 
insurance funds hospital care through a budget (eg, 
Australia and Ireland) rather than fee-for-service, which 
is common in private insurance.46 47 Similar incentives are 
present in physician payment.
Multiple studies have shown that hospitals are moti-
vated by and responsive to financial incentives,22 34 48 49 
although Grant36 argues that their impact is small. One 
example is the financial benefit associated with longer 
hospital stays associated with CS.48 50 Hospitals may incen-
tivise physicians48 49 to align their clinical decision with 
institutional strategies, such as patient-scheduling poli-
cies that steer patients with private insurance to more 
profit-prone physicians.48 49 Physicians are known to 
be motivated by higher fees paid for CS as compared 
with vaginal delivery.48 They often act as self-interested 
economic agents according to economic models of physi-
cian behaviour, by maximising income and convenience.34 
Physicians are also in a position to exploit asymmetry of 
information between them and patients,51 52 which leads 
to recommendations that are not always aligned with 
patient needs or preferences.15 There is also evidence 
that physicians with higher numbers of privately insured 
patients will tend to perform more CS34 36; explanations 
include perceptions that patients with private insurance 
have a higher social class, or more prevalent concerns 
about malpractice liability in patients with private insur-
ance.53
Comparing ‘public insurance’ and ‘private insur-
ance’ across countries is not a straightforward exercise 
as the meaning of such distinction can vary substan-
tially across countries. In the USA, ‘public insurance’ 
is insurance assigned to specific categories of popula-
tion (by age, disability, poverty or military service) and 
‘private insurance’ is insurance mainly organised through 
employment. In general, private insurance offers higher 
reimbursement rates for surgical procedures, and this 
may incentivise CS. The heterogeneity of adjusted esti-
mates across states in the USA (online supplementary 
appendix 7) points to setting specific factors that will influ-
ence the effect of insurance on the odds of CS and are 
worth of further investigation. According to Burns et al, 
the lacking association in Arizona (OR=1.02) may be due 
to equal magnitudes of reimbursements of hospitals for 
vaginal birth and CS.34 In Maryland (OR=0.96), the state 
administration introduced HealthChoice Program in 
1997, which was intended to provide prevention-oriented 
healthcare services, enact better accountability measures 
for managed care organisations and ensure efficient use 
of financial resources.38 This programme introduced a 
mandatory managed care system for Medicaid beneficia-
ries, which replaced a fee-for-service model. This resulted 
in more patients receiving managed care irrespective of 
their insurance status and, in turn, use of similar policies 
in patients with public and private insurance.38 We are 
unaware of plausible explanations for the lack of associ-
ations observed in Michigan (OR 1.01) and Ohio (OR 
1.00). This analysis shows that variation in CS rates among 
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insurers within the USA can be explained by differences 
in reimbursement arrangements nested within public 
and private insurance.
For the other two countries, Ireland and Australia, 
included in the adjusted analysis, ‘private health insur-
ance’ status differs in character from the USA but 
offers similarly higher payment levels for procedures. 
In Australia, women of childbearing age with private 
insurance would have increased the use of private obste-
tricians, leading to higher rates of CS.54 In Ireland, the 
financial incentives in private insurance are similar and 
are associated with striking inequities in care.55
Policy and research implications
Increases in the cost of care and hospital charges have 
become central issues in policy discussion in the USA 
and elsewhere.15 56 While the public healthcare costs are 
reaching unsustainable levels, hospital charges can have 
alarming effects on patients.56 In addition, the potential 
negative clinical effects of CS on mothers and newborns 
have raised concerns among clinicians, academics and 
policymakers alike.15
Recent studies and their media coverage and associ-
ated increase in public awareness of high CS rates and 
changes in reimbursement policy have led to recent 
decreases of CS rates.18 Our study provides additional 
evidence to support policy and advocacy efforts that 
address escalating CS rates, in particular their associa-
tion with financial incentives. Effective policy measures 
often require context-specific, country-specific or 
state-specific policy analyses investigating particular 
insurance schemes. These setting-specific analyses are 
essential as incentives and reimbursement arrange-
ments within health insurance schemes may differ 
across healthcare systems. We recognise that while cate-
gories ‘public insurance’ and ‘private insurance’ are 
useful markers of higher reimbursement rates, other 
aspects of insurance reimbursement may also influence 
the odds of CS.
As we analyse CS rates relation with health insurance 
schemes, we need also to be aware of the complexity of 
interaction of different determinants and their influ-
ence in CS rates. The published literature has identified 
a number of determinants of CS rates that operate at 
different levels of healthcare systems (macro, meso and 
micro).15 At the macro level of national health systems, 
operate factors such as health financing system, social 
and political context, legal regulations, general cultural 
and social norms and similar. At the meso level are hospi-
tals and healthcare facilities. Their ownership status, 
availability of resources and size are known to influence 
CS rates.15 22 Finally, at the micro level, we have clinical 
units that provide care, medical staff and patients, which 
are characterised with all sorts of features that can influ-
ence the decision for CS. For example, clinical unit staff 
composition, or physician education, gender and experi-
ence, or mother’s preference, age and race, are all known 
to determine the rates of CS.15
cOnclusIOn
This systematic review and meta-analysis indicates that 
CS are more likely to be performed in privately insured 
women as compared with women with public health 
insurance coverage. Although this effect is small and vari-
able across strata, it is present in all performed analysis. 
Review of setting-specific payment levels and reimburse-
ment arrangements within health insurance schemes will 
enable a better understanding of influencing factors. 
Efforts to address payment levels for delivery procedures 
and reform of reimbursement arrangements may lead to 
a reduction of CS rates to more appropriate levels.18 22 38 57
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